Cargando…

Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study

INTRODUCTION: Medication changes involving levothyroxine—either dose titrations or switching formulations—occur frequently in patients with erratic thyroid-stimulating hormone (TSH) levels and persistent hypothyroid symptoms. We investigated whether switching patients from levothyroxine tablets to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ernst, Frank R., Sandulli, Walter, Elmor, Riad, Welstead, Jennifer, Sterman, Arnold B., Lavan, MaryKate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318319/ https://www.ncbi.nlm.nih.gov/pubmed/27943146 http://dx.doi.org/10.1007/s40268-016-0150-z

Ejemplares similares

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study
por: Ernst, Frank R., et al.
Publicado: (2016)

Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis
por: Virili, Camilla, et al.
Publicado: (2018)

Levothyroxine Tablet Malabsorption Associated with Gastroparesis Corrected with Gelatin Capsule Formulation
por: Reardon, David P., et al.
Publicado: (2016)

SUN-590 Failure to Control Severe Hypothyroidism with L-Thyroxine Tablets Corrected by Switching to Oral Soft Gel Formulation
por: Solhjoo, Mahdis, et al.
Publicado: (2019)

Comorbidities, Concomitant Medications, and Diet as Factors Affecting Levothyroxine Therapy: Results of the CONTROL Surveillance Project
por: McMillan, Marjorie, et al.
Publicado: (2015)

Switch from tablet levothyroxine to oral solution resolved reduced absorption by intestinal parasitosis
por: Tortora, Anna, et al.
Publicado: (2019)

Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast  Improves Quality of Life of Hypothyroid Patients
por: Guglielmi, Rinaldo, et al.
Publicado: (2018)

Ionic Levothyroxine Formulations: Synthesis, Bioavailability, and Cytotoxicity Studies
por: Barreira, António, et al.
Publicado: (2023)

Levothyroxine: Conventional and Novel Drug Delivery Formulations
por: Liu, Hanqing, et al.
Publicado: (2022)

Thyroid Hormone Profile in Patients Ingesting Soft Gel Capsule or Liquid Levothyroxine Formulations with Breakfast
por: Cappelli, Carlo, et al.
Publicado: (2016)

Different Formulations of Levothyroxine for Treating Hypothyroidism: A Real-Life Study
por: Trimboli, Pierpaolo, et al.
Publicado: (2020)

Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution
por: Benvenga, Salvatore, et al.
Publicado: (2019)

Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation
por: Bone, H. G., et al.
Publicado: (2017)

Formulation preference, tolerability and quality of life assessment following a switch from lopinavir/ritonavir soft gel capsule to tablet in human immunodeficiency virus-infected patients
por: Ofotokun, Ighovwerha, et al.
Publicado: (2009)

Estimation of Potential Savings Associated With Switching Medication Formulation
por: Desai, Sunita M., et al.
Publicado: (2022)

Adherence to Levothyroxine Tablet in Patients with Hypothyroidism
por: Kumar, Rohan, et al.
Publicado: (2019)

Formulation and characterization of orodispersible tablet of glimepiride
por: Kinani, Ahmad AB Yosef, et al.
Publicado: (2022)

Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption
por: Gatta, Elisa, et al.
Publicado: (2022)

Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies
por: Kang, So-Jin, et al.
Publicado: (2023)

Studies on Formulation and In Vitro Evaluation of Floating Matrix Tablets of Domperidone
por: Prajapati, S. T., et al.
Publicado: (2009)

The performance of levothyroxine tablet is impaired by bariatric surgery
por: Trimboli, Pierpaolo, et al.
Publicado: (2022)

Spectrophotometric estimation of betahistine hydrochloride in tablet formulations
por: Kumar, Amit, et al.
Publicado: (2010)

Formulation and Evaluation of Omeprazole Tablets for Duodenal Ulcer
por: Choudhury, A., et al.
Publicado: (2010)

Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine
por: Patel, B. P., et al.
Publicado: (2010)

Formulation and evaluation of aceclofenac mouth-dissolving tablet
por: Solanki, Shailendra Singh, et al.
Publicado: (2011)

Standardization of Sulaharan Yoga: An Ayurvedic Tablet Formulation
por: Pattanayak, P., et al.
Publicado: (2011)

Formulation and evaluation of floating tablets of liquorice extract
por: Ram, H. N. Aswatha, et al.
Publicado: (2010)

Key Formulation Variables in Tableting of Coated Pellets
por: Murthy Dwibhashyam, V. S. N., et al.
Publicado: (2008)

Spectrophotometric estimation of solifenacin succinate in tablet formulations
por: Singh, Lokesh, et al.
Publicado: (2011)

Formulation and evaluation of floating matrix tablet of stavudine
por: Prajapati, Pankaj H, et al.
Publicado: (2012)

Amorphous Nanoparticulate Formulation of Sirolimus and Its Tablets
por: Shen, Yudong, et al.
Publicado: (2018)

Formulation and Evaluation of New Glimepiride Sublingual Tablets
por: Al-Madhagi, Wafa, et al.
Publicado: (2017)

Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac
por: Koirala, Santosh, et al.
Publicado: (2021)

Formulation and Characterization of an Effervescent Hydrogen-Generating Tablet
por: Rosch, Moritz, et al.
Publicado: (2021)

Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Publicado: (2023)

Mesalazine granule formulation improves clinical data in Crohn's disease compared with tablet formulation
por: Tamura, Satoshi, et al.
Publicado: (2020)

Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride
por: Mandal, Sonjoy, et al.
Publicado: (2012)

Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial
por: Richter, Manuel J., et al.
Publicado: (2018)

Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation
por: Keshavarzi, Farinaz, et al.
Publicado: (2020)

Levothyroxine Bioequivalence Study and Its Narrow Therapeutic Index: Comparative Bioavailability Results Between Two Formulations Available in Latin America
por: Bertoncini, Carlos Walter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pbdrtbqr14qqrh9012kd4fk5t9